Yoshiaki Kigawa

Colestimide Lowers Plasma Glucose Levels and Increases Plasma Glucagon-like Peptide-1 (7-36) Levels in Patients with Type 2 Diabetes Mellitus Complicated by Hypercholesterolemia

Tatsuya Suzuki, Kenzo Oba, Yoshimasa Igari et al. · Journal of Nippon Medical School · 2007 · 92 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Blood Glucose-lowering Activity of Colestimide in Patients with Type 2 Diabetes and Hypercholesterolemia: A Case-control Study Comparing Colestimide with Acarbose

Tatsuya Suzuki, Kenzo Oba, Shoko Futami et al. · Journal of Nippon Medical School · 2006 · 37 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of bile-acid-binding resin (colestimide) on blood glucose and visceral fat in Japanese patients with type 2 diabetes mellitus and hypercholesterolemia: an open-label, randomized, case–control, crossover study

Tatsuya Suzuki, Kenzo Oba, Yoshimasa Igari et al. · Journal of Diabetes and its Complications · 2012 · 28 citations

Medicine, Endocrinology, Pharmacotherapy +15

Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease

Tatsuya Suzuki, Shoko Futami‐Suda, Yoshimasa Igari et al. · Lipids in Health and Disease · 2013 · 17 citations · Full text

Medicine, Cardiology, Internal Medicine +17

The Effects of Colestimide on Blood Glucose-lowering Activity and Body Weight in Patients with Type 2 Diabetes and Hypercholesterolemia

Tatsuya Suzuki, Kenzo Oba, Shoko Futami‐Suda et al. · Journal of Nippon Medical School · 2007 · 11 citations · Full text

Medicine, Cardiology, Endocrinology +14